NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/13/2026
Back to search
Official data from USPTO
THYROID CYTOPATHOLOGY PARTNERS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THYROID CYTOPATHOLOGY PARTNERS
ST13
US500000086422930Class
44
Filing
86422930
Registration
4980679
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/02/2026
Trademark type
Word
Nice classes
44
Filing date
10/14/2014
Registration date
06/21/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2010-12-00
First use in commerce
2010-12-00
Drawing code
4
Owner type
99
Owner location
Austin, TX, US
Examiner
LEE RISO, LOKSYE GEORGIANA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Thyroid Cytopathology Partners, P.A.
Representatives
Steven M Espenshade PIRKEY BARBER PLLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services; medical services in the fields of pathology and cytopathology; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; medical consultation services
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/13/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/13/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
03/10/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/21/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/17/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/17/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/17/2021
E815
TEAS SECTION 8 & 15 RECEIVED
08/13/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/21/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/21/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/05/2016
PUBO
PUBLISHED FOR OPPOSITION
04/05/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/16/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/29/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/18/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/18/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/20/2015
GNFR
FINAL REFUSAL E-MAILED
08/20/2015
CNFR
FINAL REFUSAL WRITTEN
08/20/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2015
GNRT
NON-FINAL ACTION E-MAILED
02/03/2015
CNRT
NON-FINAL ACTION WRITTEN
02/03/2015
DOCK
ASSIGNED TO EXAMINER
02/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/20/2014
NWAP
NEW APPLICATION ENTERED
10/17/2014
Continuous trademark protection
Get notified about every new filing that threatens THYROID CYTOPATHOLOGY PARTNERS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.